Improve-it trial summary
WitrynaRationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of … WitrynaVytorin Efficacy International Trial (IMPROVE-IT) evaluated the effect of ezetimibe combined with simvastatin, as compared with that of simva-statin alone, in stable …
Improve-it trial summary
Did you know?
Witryna19 lis 2014 · IMPROVE IT posiblemente inducirá algún cambio en las guías en futuras revisiones. Otra posibilidad es que pueda ayudar a evitar la posibilidad de … WitrynaFindings In a prespecified analysis of 15 281 patients enrolled in IMPROVE-IT, patients achieving an LDL-C level of less than 30 mg/dL at 1 month after acute coronary …
WitrynaRecent findings: IMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin … WitrynaIn order to improve compliance on the posting of results, the primary aim of this communication is to remind all sponsors about their obligation for the reporting of clinical trial summaries in the EU Clinical Trials Database. In the spirit of the EU legislation, it is important that all stakeholders act
WitrynaOther trials have shown that digital adherence technologies (SMS-based and those based on medication event reminder monitors), implemented in real-time, can … Witryna1 cze 2024 · PINNACLE Cohort and IMPROVE-IT Trial Patient Characteristics View LargeDownload 1. Cannon CP, Blazing MA, Giugliano RP, Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387-2397. PubMedGoogle ScholarCrossref 2. Maddox TM, Masoudi FA, Oetgen
Witryna1 wrz 2024 · This trial is registered at ClinicalTrials.gov, NCT00125593, and ISRCTN54137607. 4650 patients were assigned to receive simvastatin plus ezetimibe and 4620 to placebo.
Witryna10 cze 2014 · It is predicted, therefore, the trial will complete in 2014. IMPROVE-IT when reported will be the largest and longest contemporary trial focusing specifically on … first state dividend advantage 2012 factsheetWitrynaThe Pravastatin or Atorvastatin Evaluation and Infection Therapy trial (PROVE-IT/TIMI-22) showed that in patients with acute coronary syndromes, aggressive lipid-lowering using atorvastatin 80 mg/day provided greater protection against death or major cardiovascular events than did moderate lipid-low … Lessons from the PROVE-IT trial. first state dividend advantage fund factsheetWitrynaSummary The Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) was a large double-blind, randomised controlled trial to investigate … first state dispensary menuWitrynaIMPROVE-IT TRIAL; Problem: Recent acute coronary syndrome with raised LDL: Format: Double-blind RCT: Treatment: Ezetimibe 10mg + Simvastatin 40mg: Control: … campbell river to sayward distanceWitrynaplacebo‐controlled trial design, the benefit could have been due to the statin alone. SHARP What IMPROVE‐IT may add? Ezetimibe may modestly lower CV event risk … campbell river tree serviceWitryna23 lis 2024 · When to write a summary. Step 1: Read the text. Step 2: Break the text down into sections. Step 3: Identify the key points in each section. Step 4: Write the summary. Step 5: Check the summary against the article. Frequently asked questions about summarizing. first state dividend advantage factsheetWitryna3 lut 2024 · Lay Summary Non-Hispanic Black Americans experience the highest, and most rapidly increasing, rates of obesity and diseases attributed at least in part to poor diet quality. In contrast to restrictive diets, which can be ineffective and often harmful, there is a well-established connection between home cooking and lower body mass … campbell river used boats craigslist